Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05553600 · ClinicalTrials.gov registry record · NA
Tampon Design Validation Study
A NA study, sponsored by Kimberly-Clark Corporation.
- Completed
- Registry status
- NA
- Development phase
- 732
- Enrollment target
NCT05553600: Completed NA study, sponsored by Kimberly-Clark Corporation.
NCT05553600 is a NA study that has completed, run by Kimberly-Clark Corporation. The registered enrollment target is 732 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05553600, a NA study, has completed, sponsored by Kimberly-Clark Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 732 participants
- Enrollment target
Study Summary
This prospective multi-center, open-label, randomized, cross-over study is designed to validate the user needs of a tampon design. The hypothesis is that user needs are met.
Primary Outcome
The percentage of used tampons within each test code that have elongated \>10mm. The denominator for the percentage calculation is based upon the number of used tampons returned within each test code.
Interventions
- DEVICE Tampon BR
- DEVICE Tampon CR
- DEVICE Tampon BS
- DEVICE Tampon CS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 732 participants |
| Start Date | 2022-10-21 |
| Est. Completion | 2023-05-05 |
| Phase | NA |
What the finished NCT05553600 record still lists
NCT05553600 is an interventional study that assigns participants to a tested intervention. The registered 732 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (48% lower).
The record links to 0 conditions, and to 4 interventions - of which Tampon BR is the first listed.
NCT05553600 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05553600 about?
NCT05553600 is a clinical study titled "Tampon Design Validation Study". This prospective multi-center, open-label, randomized, cross-over study is designed to validate the user needs of a tampon design. The hypothesis is that user needs are met.
What is the current status of trial NCT05553600?
This trial is currently completed. It is a NA study. The enrollment target is 732 participants. The study started on 2022-10-21. Estimated completion is 2023-05-05.
What interventions are being tested in trial NCT05553600?
The interventions under investigation include: Tampon BR (DEVICE), Tampon CR (DEVICE), Tampon BS (DEVICE), Tampon CS (DEVICE).
Who is sponsoring clinical trial NCT05553600?
This trial is sponsored by Kimberly-Clark Corporation, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05553600's enrollment target sits among peer trials
732 145th of 2000 higher than 1,856 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06216301 · 734 participants · Phase 3
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
- NCT07231419 · 734 participants · Phase 3
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
- NCT03232918 · 730 participants · Phase 4
Oxytocin and Fetal Heart Rate Changes
- NCT05548283 · 730 participants · Phase 4
Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI